Results 161 to 170 of about 244,384 (286)
[Progress on matrix metalloproteinase inhibitors]. [PDF]
Hua Xi Kou Qiang Yi Xue Za Zhi, 2017 Lingling J, Qianbing W.
europepmc +1 more source
Matrix metalloproteinase inhibitors: current developments and future perspectives.
The Oncologist, 2001 Rosa Hoekstra, F. Eskens, Jaap Verweij
semanticscholar +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source
Effects of matrix metalloproteinase inhibitors on N-methyl-D-aspartate receptor and contribute to long-term potentiation in the anterior cingulate cortex of adult mice. [PDF]
Mol Pain, 2019 Matsuura T, Li XH, Tao C, Zhuo M.
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou +7 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1374-1385, April 2025.Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu +9 more
wiley +1 more source
Matrix Metalloproteinase Inhibitors in Cancer Therapy
Cancer Drug Discovery and Development, 2000 N. Clendeninn, K. Appelt
semanticscholar +1 more source
Matrix metalloproteinase inhibitors: Present achievements and future prospects
Investigational new drugs, 1997 L. Denis, J. Verweij
semanticscholar +1 more source